Measuring brain-surface iron with MRI in superficial siderosis
Official title: Haemdall: Developing a Quantitative MRI Biomarker of Classical (Infratentorial) Superficial Siderosis of the Central Nervous System
Run by Perspectum · NCT07098650 · Data updated 2026-11-12
This project will try a new MRI technique to measure iron on the surface of the brain in adults with superficial siderosis and compare findings to healthy adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Perspectum Industry-sponsored |
| Locations | 1 site (Oxford) |
| Status | Recruiting |
| Started | August 14, 2025 |
| Main results expected | October 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 20, 2025 |
| Trial ID | NCT07098650 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults (18+) with a confirmed diagnosis of superficial siderosis who can consent and communicate in English, or healthy adults without neurological disorders to serve as controls.
✕Probably not a fit
People under 18, those without a confirmed diagnosis, individuals who cannot undergo MRI due to incompatible implants or severe claustrophobia, or those unable to give informed consent are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project uses quantitative susceptibility mapping (QSM), an MRI method, to quantify iron accumulation on the brain surface in people with infratentorial superficial siderosis and in healthy control participants. Participants will have specialized MRI scans and a battery of clinical tests including hearing evaluations, walking and balance assessments, and cognitive testing. Researchers will compare the MRI-derived iron measurements with symptom severity to see if imaging signals relate to clinical features. All imaging and clinical assessments are conducted on-site at Perspectum in Oxford and are noninvasive apart from standard MRI safety considerations.
Why it matters
Potential benefit: If successful, the technique could provide a noninvasive MRI biomarker to track iron burden and help monitor disease progression or responses to future treatments.
How similar studies have gone: Quantitative susceptibility mapping has been used successfully to map brain iron in disorders such as Parkinson's disease and multiple sclerosis, but applying QSM specifically to infratentorial superficial siderosis is relatively novel and not yet widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Superficial siderosis cohort: * Male or female adults of 18 years of age or older with a confirmed diagnosis of superficial siderosis * Participants who have the capacity and a level of English proficiency that allows him/her to communicate well with the Investigator, understand and comply with the requirements of the investigation, read all participant facing documentation, as well as read and sign the informed consent form. * Participants willing and able to give informed consent for participation in the investigation Healthy cohort: * Male or female over 18 years of age without a diagnosis of a neurological disorder * Participants who have the capacity and a level of English proficiency that allows him/her to communicate well with the Investigator, understand and comply with the requirements of the investigation, read all participant facing documentation, as well as read and sign the informed consent form. * Participants willing and able to give informed consent for participation in the investigation Exclusion Criteria: * The participant may not enter the investigation if they have any contraindication to magnetic resonance imaging (including pregnancy, extensive tattoos, pacemaker, shrapnel injury or metallic unfixed implanted devices, metallic fragments, severe claustrophobia and cochlear implants) * Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the investigation, or may influence the result of the investigation, or the participant's ability to participate in the investigation * Participants who do not demonstrate the capacity to understand the investigation information or provide informed consent
Where it's running
-
Perspectum
Oxford, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Global Reference Ranges for Healthy Adults in Singapore
This study tests healthy adults in Singapore to establish normal MRI-based reference values for liver and body measurements and to see if these ranges differ by ethnicity.
-
Improving MRI techniques for multiple organs in healthy volunteers
This study is testing new MRI techniques on healthy volunteers to see if they can improve the quality and consistency of scans for different organs.
-
Seeing Diabetes Clearly: multi-organ MRI of organ health in adults with type 2 diabetes
This project will use a detailed abdominal and multi-organ MRI plus blood and urine tests to see if imaging measurements can predict future health events in adults with type 2 diabetes who have not had heart disease.
-
Non-Invasive Assessment of Liver Health in Patients with NASH
This study is testing a new imaging method to see if it can accurately identify patients with Nonalcoholic Steatohepatitis (NASH) without needing a liver biopsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.